neuromuscular blockade was effected by the administration of neostigmine (2.5 mg) and atropine (1.2 mg). The patient was slow to wake, which was presumed to be the residual effect of isoflurane as the anaesthetic agent monitor still registered an end-tidal isoflurane concentration of 0.1-0.2070. She was extubated when spontaneous respiration had returned with an EtC02 in the order of 45 mmHg and signs of recovery from anaesthesia were noted. She was transferred to the recovery room. The duty anaesthetist was called to see her approximately 15 minutes later as she was not breathing adequately. She was found at that time to be unresponsive, with little respiratory effort. Ventilation was effected by bag and mask with 100% 02. She had a good airway, Sa02, pulse and blood pressure. Initially naloxone was given (400 p.g in divided doses) with no effect, followed by doxapram (60 mg). The latter produced a very brief minimal effect with some slight twitching and short-lived very weak respiratory activity. A poor reversal of neuromuscular blockade was apparent clinically and despite there being four good twitches following TOF stimulation at the ulnar nerve, a further small dose of neostigmine (1.25 mg) and atropine (0.9 mg) was given.
This produced some twitching of her limbs and some respiratory activity of brief duration, but this was almost exclusively in the accessory muscles of respiration. At this stage, about four or five minutes after the initial call to the recovery room, as there was no obvious improvement in her condition, she was reintubated following a dose of propofol (lOO mg). The differential diagnosis included stroke or a myastheniclike condition. To confirm once more the degree of neuromuscular blockade, TOF stimulation was again applied, on this occasion to the facial nerve. An appreciable degree of fade was apparent to both TOF and tetanic stimulation, which was not visible when the test was repeated at the ulnar nerve. Failure to recover from neuromuscular blockade combined with a history of malignant disease suggested a possible diagnosis of Lambert-Eaton syndrome.
The patient was referred to the intensive care unit Anaesthesia and Intensive Care, Vol. 23, No. 1, February, 1995 (ICU) for ventilation until muscle power returned. She was breathing spontaneously on a T-piece after four hours, and was extubated two hours later. She was transferred to the ward two days later. While on ICU further enquiry revealed a history of increasing weakness over the preceding six months. She had been playing golf to quite a high standard but was now unable to due to weakness. She also complained of inability to comb her hair, especially over the occipital region. Closer examination suggested that she had some ptosis on the non-operated side and weakness of her upper limbs. Following discharge from the ICU she was referred to a neurologist. The clinical and electromyographic (EMG) diagnosis was that of myasthenia gravis. Unfortunately before appropriate therapy could be started, she promptly relapsed, having a further respiratory arrest. Once again she was resuscitated and transferred back to the ICU, where therapy with pyridostigmine was commenced and she was subsequently extubated. The remainder of her hospital stay was uncomplicated.
DISCUSSION
Myasthenia gravis and Lambert-Eaton syndrome are two conditions which may present first to the anaesthetist, either pre-or postoperatively. The anaesthetist must therefore always be alert to the clinical signs and symptoms of these two diseases.
Myasthenia gravis is an autoimmune defect caused by antibodies directed against acetlycholine (ACh) receptors at the post junctional membrane 1 ,2. Antibody binds not to the ACh receptor itself but close to it on the receptor protein, decreasing the binding of ACh 3 . This produces a fluctuating weakness which varies throughout the day. Ocular involvement (diplopia and ptosis) and bulbar symptoms (dysphagia and dysarthria) are most common. Painless distal and proximal muscle weakness usually only follows after muscles of the head and neck. It occurs in three times as many females as males between the ages of 10 and 40 years, after which the incidence is equal. Electromyographic studies show normal to slightly reduced evoked compound muscle action potential and fade in response to repetitive stimulation. There is resistance to suxamethonium 4 , and extreme sensitivity to nondepolarizing relaxants 5 . In this case, the resistance to suxamethonium was not obvious but the sensitivity to vecuronium was seen, as well as the characteristic EMG recording.
Lambert-Eaton syndrome (the myasthenic syndrome), is a disorder of neuromuscular transmission first recognized clinically in association with lung cancerli,7. It has since been observed in patients with AnoeslhesioondlntensiveCore, Vol. 23, No. I, February, 1995 thoracic extensions of breast, prostate, stomach and rectal carcinoma. It also appears to be caused by autoantibodies to cationic channels. Two features have identified the disorder as presynaptic in origin. They are the decreased number of ACh quanta released from motor nerve terminals by each nerve impulse 7 and the demonstration of autoantibodies directed against the voltage gated calcium channels at the motor nerve ter-minaI 8 ,9. The clinical features are of proximal muscle weakness, mainly of the lower limbs. Ocular and bulbar weakness does occur but is rare. There is a decreased muscle response to a single electrical stimulus but, in contrast to myasthenia gravis, there is facilitation and not fade following repetitive stimulation. Sensitivity to both suxamethonium and non depolarizing relaxants is seen. There is a poor response to anticholinesterase drugs, but 3,4-diaminopyridine has been effective in increasing muscle strength 'o • Despite the history of previous malignant disease in this patient, the finding of fade to tetanic stimulation should have suggested a diagnosis of myasthenia gravis, although the clinical findings on the ICU, after the patient had been extubated, were more equivocal.
One of the problems in making a diagnosis was the apparently good response to TOF stimulation at the wrist. It is recognized that purely visual interpretation of the TOF ratio can be misleading". However, stimulation of the facial nerve produced a response that was noticeably different to the same observers. It is known that neuromuscular blocking drugs have differing effects on peripheral and respiratory muscle with more profound effects being demonstrated in, for example, the adductor pollicis than on the diaphragm l2 • Intercostal and accessory muscles of respiration, as well as muscles of the upper airway may also be more sensitive to neuromuscular blocking agents than the diaphragm'3.
Another point concerns the use of doxapram. This drug given in isolation augments neuromuscular transmission, but in the presence of nondepolarizing relaxants, recovery may be prolonged l4 • It would appear that doxapram should be avoided in cases where there is doubt about the recovery of neuromuscular function.
When choosing a muscle relaxant in a case of known or suspected myasthenia gravis (or any neuromuscular problem) the ideal drug would be one which does not accumulate. Atracurium has been recommended as the drug of choice'5 due to its rapid elimination.
This case highlights the need for a high index of suspicion and careful preoperative assessment prior to surgery. The importance of neuromuscular monitoring also should be emphasised in order to assess the degree of relaxation as well as providing essential information in the differential diagnosis of poor recovery after anaesthesia. However, if the clinical picture does not fit with the results of roF monitoring, the anaesthetist should consider testing for neuromuscular function at another site.
